Abcellera Biologics Inc.
SEC CIK 1703057 · ABCL · last insider filing 2026-06-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hayden Michael R | Director | filed 2020 - 2026 |
| Quake Stephen | Director | filed 2025 - 2026 |
| Montalbano John S. | Director | filed 2020 - 2026 |
| Sandor Victor | Director | filed 2026 - 2026 |
| Hansen Carl L. G. | Director · Chief Executive Officer | filed 2020 - 2026 |
| Lecault Veronique | Director · Chief Technology Officer | filed 2020 - 2026 |
| Lo Andrew | Director | filed 2021 - 2025 |
| Hamer John | Director | filed 2020 - 2021 |
| Thiel Peter | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Booth Andrew | Chief Financial Officer | filed 2020 - 2026 |
| Stimart Tryn | Chief Legal Officer | filed 2020 - 2026 |
| Falconer Ester | Chief Technology Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.